Clinical outcomes of pembrolizumab plus chemotherapy for postoperative recurrent esophageal squamous cell carcinoma. - Sugase T; Kanemura T; Matsuura N; Sugimura K; Takeoka T; Ushimaru Y; Masuike Y; Yanagimoto Y; Mori R; Kitakaze M; Kubo M; Mukai Y; et al. (Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2025)